Tolterodine Tartrate Capsule, Extended Release
Product Images NDC 70436-160

11 FDA label images from Slate Run Pharmaceuticals, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Tolterodine Tartrate (NDC 70436-160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ink3 (Ink3)

Ink3 (Ink3)
Tolterodine Tartrate 4 mg extended release capsules in a transparent plastic blister pack containing 28 capsules. Each capsule is colored orange and white with imprint visible. Manufactured or labeled by Slate Run Pharmaceuticals, LLC.*
FDA Label Image

Ink4 (Ink4)

Ink4 (Ink4)
Tolterodine Tartrate 2 mg extended release capsules in a blister pack. The image shows capsules with pink and beige colors in a silver foil blister packaging. The brand or labeler, Slate Run Pharmaceuticals, LLC, is not visible on the pack itself.*
FDA Label Image

Chemical Structure (Detrol La 01)

Chemical Structure (Detrol La 01)
Chemical structure of Tolterodine Tartrate showing the molecular arrangement of its chemical groups, including the tolterodine base and tartrate moiety.*
FDA Label Image

Ink1 (Ink1)

Ink1 (Ink1)
Tolterodine Tartrate extended release capsules, 2 mg and 4 mg strengths, packaged in a white box with black text. The label displays the generic name and dosage form, with the Slate Run Pharmaceuticals, LLC labeler name visible. The packaging includes a blister pack containing capsules.*
FDA Label Image

Ink2 (Ink2)

Ink2 (Ink2)
Tolterodine Tartrate 2 mg extended release capsules packaging label. The label features the product name and strength prominently, includes a green and white color scheme, and the labeler Slate Run Pharmaceuticals, LLC. The dosage form is oral extended release capsules.*
FDA Label Image

2mg-30ct (2mg 30ct Spain)

2mg-30ct (2mg 30ct Spain)
Tolterodine Tartrate Extended-Release Capsules USP 2 mg label by Slate Run Pharmaceuticals, LLC. The package contains 30 capsules, child-resistant container, with storage instructions between 20° to 25°C. The product is distributed by Slate Run Pharmaceuticals in Columbus, Ohio and is a product of Spain. Barcodes and lot/serialization data area are also visible on the label.*
FDA Label Image

2mg-90ct (2mg 90ct Spain)

2mg-90ct (2mg 90ct Spain)
Packaging label for Tolterodine Tartrate Extended-Release Capsules, USP 2 mg, manufactured by Slate Run Pharmaceuticals, LLC. The label indicates 90 capsules in the package, includes storage instructions, child-resistant packaging notice, and usual dosage reference. The product is distributed from Columbus, Ohio, and is identified as a product of Spain.*
FDA Label Image

2mg-500ct (2mg 500ct Spain)

2mg-500ct (2mg 500ct Spain)
Label for Tolterodine Tartrate Extended-Release Capsules USP 2 mg by Slate Run Pharmaceuticals, LLC. The oral capsule package contains 500 capsules. It includes storage instructions, dispensing warnings, and batch information, with a barcode on the right side.*
FDA Label Image

4mg-30ct (4mg 30ct Spain)

4mg-30ct (4mg 30ct Spain)
Label for Tolterodine Tartrate Extended-Release Capsules, USP 4 mg by Slate Run Pharmaceuticals, LLC. The package contains 30 capsules. It includes storage instructions, dosage form, distributor information, and a barcode. The capsules are for oral use and the product is made in Spain.*
FDA Label Image

4mg-90ct (4mg 90ct Spain)

4mg-90ct (4mg 90ct Spain)
Label for Tolterodine Tartrate Extended-Release Capsules, USP, 4 mg strength by Slate Run Pharmaceuticals, LLC. The package contains 90 capsules. The label includes dosage form as extended-release capsules and storage instructions. It also notes the product is from Spain and contains child-resistant packaging.*
FDA Label Image

4mg-500ct (4mg 500ct Spain)

4mg-500ct (4mg 500ct Spain)
Label for Tolterodine Tartrate Extended-Release Capsules, USP 4 mg, by Slate Run Pharmaceuticals, LLC. The label states the product contains 500 capsules and includes storage instructions, dosage guidance to see package insert, and distribution information. The NDC is 70436-161-02.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.